Name | ALK5-IN-29 |
---|
Description | ALK5-IN-29 is an selective activin receptor-like kinase (ALK) inhibitor. ALK5-IN-29 can inhibit the activity of ALK5 with an IC50 value of ≤10 nM. ALK5-IN-29 also has inhibitory of tumor growth and can be used for the research of proliferative diseases, such as cancer[1]. |
---|---|
Related Catalog | |
Target |
IC50: ≤10 nM (ALK5/2); ≤100 nM (RD-SMAD receptor)[1] |
In Vitro | ALK5-IN-29 (EX-06) has kinase inhibition of ALK5 with an IC50 value of ≤10 nM[1]. ALK5-IN-29 has kinase selectivity of ALK2/ALK5 with an IC50 value of ≤10 nM[1]. ALK5-IN-29 shows TGFB-RI inhibition (RD-SMAD receptor activity) with an IC50 value of ≤100 nM[1]. |
References |
[1]. Bettina FRANZ, et al. Alk-5 inhibitors and uses thereof. Patent. WO2022126133A1. |
Molecular Formula | C24H25FN8 |
---|---|
Molecular Weight | 444.51 |